VIENNA — HD Immune GmbH (HDI), a privately held biotechnology company developing novel antibody treatments for Huntington’s Disease, announces commencement of operations by its two founders Dr. Stefan ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results